Tandem Diabetes Care, based in San Diego, focuses on products for insulin-dependent diabetes, employing 2,400 staff since its IPO in 2013. Its advanced insulin pumps, including the t:slim X2, feature Control-IQ technology and are compatible with various CGM sensors.
John F Sheridan bought 10,000 shares of TNDM on 11 August at $10.23 per share, worth a total of $102K. They now own 106,327 TNDM shares, or a 10% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
